Art

J-GLOBAL ID：201202267224995133   Reference number：12A0076202

Studies of the efficacy and safety of methotrexate at dosages over 8mg/week using the IORRA cohort database

IORRAコホートデータベースを使用した8mg/週以上の投与量でのメソトレキセートの効果と安全性の研究

Author (7)： SETO Yohei (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  TANAKA Eiichi (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  INOUE Eisuke (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  NAKAJIMA Ayako (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  TANIGUCHI Atsuo (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  MOMOHARA Shigeki (Tokyo Women’s Medical Univ., Tokyo, JPN) ,  YAMANAKA Hisashi (Tokyo Women’s Medical Univ., Tokyo, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 21  Issue： 6  Page： 579-593  Publication year： 2011 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： rheumatoid arthritis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0076202&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (1)： Methotrexate

Reference (38)：

• WEINBLATT, ME. The effects of drug therapy on radiographic progression of rheumatoid arthritis : results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum. 1993, 36, 613-619
• CANNELLA, AC. Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?. Curr Opin Rheumatol. 2003, 15, 185-192
• YAZICI, Y. Long term safety of methotrexate in routine clinical care : discontinuation is unusual and rarely the result of laboratory abnormalities. Ann Rheum Dis. 2005, 64, 207-211
• SMOLEN, JS. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. Lancet. 2008, 371, 987-997
• MEASE, PJ. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab : results of the dose-ranging assessment : international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) trial. J Rheumatol. 2008, 35, 20-30

Terms in the title (6)： IORRAコホート ,  データベース ,  投与量 ,  メソトレキセート ,  安全性 ,  研究